Shijiazhuang Yiling Pharmaceutical Co: Revenue and profit declined sharply year-over-year, but operating cash flow improved

About this update from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

Q3 2024 revenue fell 1.3% year-over-year, with net profit down 84.07%. YTD revenue and profit dropped sharply due to lower demand and reduced government support, but operating cash flow improved significantly.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A